BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35122206)

  • 1. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report.
    Shieh M; Giannini JA; Combs SA; Shaffi SK; Messias NC; Teixeira JP
    CEN Case Rep; 2022 Aug; 11(3):380-385. PubMed ID: 35122206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
    Bridoux F; Javaugue V; Nasr SH; Leung N
    Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative Glomerulonephritis With Monotypic Immunoglobulin Deposits: An Unusual Presentation in the Setting of Multiple Inciting Events Including COVID-19 Vaccination.
    Vanjarapu JMR; Iglesias J; Ahmed R; Singh P; Gerbino G; Stokes MB
    Cureus; 2022 Jun; 14(6):e25949. PubMed ID: 35855226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.
    van Kruijsdijk RCM; Abrahams AC; Nguyen TQ; Minnema MC; Jacobs JFM; Limper M
    J Nephrol; 2020 Jun; 33(3):611-617. PubMed ID: 32221859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report.
    Ito D; Shiozaki Y; Shimizu Y; Suzuki Y; Takeda A; Misaki T
    BMC Nephrol; 2022 Dec; 23(1):396. PubMed ID: 36494791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) that responded favorably to steroid therapy.
    Ogura Y; Yabushita S; Aihara H; Tsukada H; Hashiba T; Furuse S; Fujii A; Ueda Y; Mise N
    CEN Case Rep; 2022 May; 11(2):208-215. PubMed ID: 34628583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    Liu M; Yu X; Wang S; Qin A; Zhou F; Zhao M
    J Nephrol; 2022 Dec; 35(9):2363-2372. PubMed ID: 35460458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronological change of renal pathological findings in the proliferative glomerulonephritis with monoclonal IgG deposits considered to have recurred early after kidney transplantation.
    Katsuno T; Kato M; Fujita T; Tsuboi N; Hattori R; Ito Y; Maruyama S
    CEN Case Rep; 2019 Aug; 8(3):151-158. PubMed ID: 30805792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
    Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
    Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGNMID and anti-CD38 monoclonal antibody: a therapeutic challenge.
    Rahbari E; Barreca A; Nicolino B; Ciochetto C; Piraina V; Maroni S; Deagostini MC; Patti R; Bertucci P; Savoldi S
    G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Li M; Xu G
    Clin Kidney J; 2022 Jun; 15(6):1041-1048. PubMed ID: 35664272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-sensitive recurrent mesangial proliferative glomerulonephritis with monoclonal IgG deposits.
    Nomura K; Miyatake N; Okada K; Hayashi N; Fujimoto K; Adachi H; Furuichi K; Shimizu A; Yokoyama H
    CEN Case Rep; 2021 May; 10(2):308-313. PubMed ID: 33398782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
    Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
    Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    Wu Q; Liang D; Song T; Ni X; Wu X; Zhang M; Chen J; Cheng D; Xie K; Li X; Wen J
    J Nephrol; 2023 Jan; 36(1):93-101. PubMed ID: 35867238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of recurrent proliferative glomerulonephritis with monoclonal IgG deposits or de novo C3 glomerulonephritis after kidney transplantation.
    Tamura T; Unagami K; Okumi M; Kakuta Y; Horita S; Ishida H; Koike J; Honda K; Tanabe K; Nitta K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():76-80. PubMed ID: 29968411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Sato K; Makabe S; Iwabuchi Y; Kojima K; Sato M; Kataoka H; Moriyama T; Taneda S; Tsuchiya K; Nitta K; Mochizuki T
    Nephrology (Carlton); 2018 Aug; 23(8):787-790. PubMed ID: 29577510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of proliferative glomerulonephritis with monoclonal IgG deposits in pediatric patients.
    Miller P; Xiao AY; Kung VL; Sibley RK; Higgins JP; Kambham N; Charu V; Lenihan C; Uber AM; Talley EM; Arora N; Walavalkar V; Laszik ZG; Nast CC; Troxell ML
    Pediatr Nephrol; 2021 Apr; 36(4):927-937. PubMed ID: 33044675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit.
    Maity P; Dasgupta S; Basu K; Sengupta M; Chowdhury AR; Bandopadhyay M
    Indian J Pathol Microbiol; 2021; 64(2):282-287. PubMed ID: 33851621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
    Zhang F; Gao E; Liang S; Yang N; Wang J
    Ann Clin Lab Sci; 2018 Jul; 48(4):528-533. PubMed ID: 30143498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.